×
About 258 results

ALLMedicine™ Extranodal Lymphoma Center

Research & Reviews  95 results

Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
https://clinicaltrials.gov/ct2/show/NCT05390632

May 25th, 2022 - In this study investigators evaluated Nodal and Extranodal Lymphoma Lesions uptake by 18F-FDG PET (PET/CT and PET/MR). Prior to treatment, all patients will undergo whole-body 18F-FDG PET/CT and PET/MR. The methods' efficiency was compared in the ...

The Central Cavitation in Pulmonary Diffuse Large B-Cell Lymphoma Detected by 18F-FDG P...
https://doi.org/10.1097/RLU.0000000000004173
Clinical Nuclear Medicine; Lin N, Xie H et. al.

Apr 20th, 2022 - Primary pulmonary diffuse large B-cell lymphoma is a rare type of extranodal lymphoma with PET/CT manifestations of consolidations, ground-glass opacities, and high 18F-FDG uptake. Because of its rarity and the lack of typical imaging features, it...

Lymphomas of the Head and Neck Clinical Presentation
http://emedicine.medscape.com/article/854110-clinical

Mar 3rd, 2022 - History Lymphoma may be nodal or extranodal. Extranodal lymphoma is usually NHL and worsens the patient's prognosis. HL extends by means of contiguous nodal spread; therefore, it is often localized and frequently occurs in the mediastinum. NHL ten...

Primary Breast Lymphoma Detected by 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT.
https://doi.org/10.1097/RLU.0000000000003961
Clinical Nuclear Medicine; Tao Y, Wang F et. al.

Jan 13th, 2022 - Primary breast lymphoma is a rare form of extranodal lymphoma. We report 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT findings of breast lymphoma in a 60-year-old woman. Both breast ultrasound and mammogram showed a mass in the right breast and suggested ...

Clinical Outcomes of RTOG 9310 Protocol for Primary Central Nervous System Lymphoma: Si...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628744
Current Oncology (Toronto, Ont.); Kim J, Kim TG et. al.

Dec 14th, 2021 - The Radiation Therapy Oncology Group (RTOG) 9310 protocol clinical trial established high-dose methotrexate (HDMTX) as the standard for primary central nervous system lymphoma (PCNSL). We aimed to investigate the RTOG 9310 protocol's PCNSL outcome...

see more →

Guidelines  1 results

Primary extranodal lymphoma of the glands. Literature review and options for best pract...
https://doi.org/10.1016/j.critrevonc.2019.01.005
Critical Reviews in Oncology/hematology; Belkacemi Y, Sio TT et. al.

Mar 2nd, 2019 - Primary extranodal non-Hodgkin's lymphomas (EN-NHL) are a heterogeneous group of malignancies that involve numerous entities with significant difference in terms of tumor site locations, prognostic factors, biology expression, and therapeutic opti...

see more →

Clinicaltrials.gov  3 results

Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
https://clinicaltrials.gov/ct2/show/NCT05390632

May 25th, 2022 - In this study investigators evaluated Nodal and Extranodal Lymphoma Lesions uptake by 18F-FDG PET (PET/CT and PET/MR). Prior to treatment, all patients will undergo whole-body 18F-FDG PET/CT and PET/MR. The methods' efficiency was compared in the ...

Study in Patients With Primary Breast Diffuse Large B-cell Lymphoma
https://clinicaltrials.gov/ct2/show/NCT01448096

Aug 7th, 2019 - Primary breast diffuse large B-cell lymphoma (DLBCL) is a rare presentation of non-Hodgkin's lymphoma. A significant risk of contralateral breast involvement and a tendency for central nervous system (CNS) progression have been identified in previ...

Endomicroscopy and Gastric MALT-lymphoma
https://clinicaltrials.gov/ct2/show/NCT01583699

Jul 21st, 2015 - Introduction Extranodal marginal zone B-cell lymphoma (MZBL) of the mucosa associated lymphoid tissue (MALT-lymphoma) is the most common form of extranodal lymphoma [1, 2]. Although MALT-lymphoma may involve different organs, the stomach represent...

see more →

News  4 results

Temporalis Muscle Thickness Predicts CNS Lymphoma Survival
https://www.medscape.com/viewarticle/964469

Dec 9th, 2021 - Key Takeaway Sarcopenia measured by temporalis muscle thickness (TMT) robustly and independently predicts early relapse and short survival in primary central nervous system (CNS) lymphoma. Very thin TMT is a better predictor of mortality than the ...

Rituximab, Thiotepa, and Chemo Combo Improves Outcomes in Primary CNS Lymphoma
https://www.onclive.com/view/adding-rituximab-and-thiotepa-to-chemo-doublet-improves-outcomes-in-primary-cns-lymphoma

Dec 20th, 2020 - Andrés Ferreri, MD The MATRIX regimen, comprised of a methotrexate/cytarabine backbone plus thiotepa and rituximab, improved outcomes in patients with primary CNS lymphoma, according to results from the international randomized phase II ELSG #3...

Thiotepa, rituximab improve response in CNS lymphoma
https://www.mdedge.com/hematology-oncology/article/188649/lymphoma-plasma-cell-disorders/thiotepa-rituximab-improve-response-cns
Erilyn Riley

Jun 24th, 2015 - Palazzo Dei Congressi, site of 13-ICML LUGANO—Adding thiotepa and rituximab to the treatment of primary central nervous system (CNS) lymphoma is feasible from a safety perspective and has yielded promising results, according to new research. An an.

Rituximab plus chlorambucil extend event-free survival in MALT lymphoma
https://www.mdedge.com/hematology-oncology/article/75981/lymphoma-plasma-cell-disorders/rituximab-plus-chlorambucil-extend
Sharon Worcester

Jul 3rd, 2013 - Patients who have mucosa-associated lymphoid tissue lymphoma and are treated with chlorambucil plus rituximab have better event-free survival and progression-free survival than do comparable patients treated with either drug alone, according to fi.

see more →